Oral infection of suckling mice has been reported recently by Ujiiye and associates (18, 19) and others (1) as a useful model of experimental cholera. The response to successful infection was the accumulation of fluid in the intestines, diarrhea, and death. Passive protection of suckling mice, born to appropriately immunized mothers, has been demonstrated against oral (18) and intraperitoneal (16) challenge with virulent vibrios. In contrast to the reported placental transmission of protection to the suckling rabbit (14) , only protection via colostrum or milk could be positively demonstrated in the suckling mouse.
Present knowledge of the immunology of cholera is not yet sufficient to resolve the relative contributions of antitoxic and antibacterial immunity to effective prophylaxis against human cholera. However, a number of reports, particularly the extensive studies of Freter (6) (7) (8) 10) , have established the importance of "local immunity" dependent upon the presence of coproantibody. Oral challenge of passively immunized suckling mice would seem to be a better measure of protection provided by cholera vaccines than the intraperitoneal challenge of the standard mouse protective test.
Considerable evidence has accumulated to suggest that immunization with subcellular preparations of a number of bacterial pathogens provides a substantial degree of protection against challenge with the homologous orga- ' (16) . The duration of protection was related to the quantity of vaccine given to the mother.
The production and isolation of cholera toxin in highly purified form by Finkelstein and Lo Spalluto (5) has allowed a more thorough study of its role in cholera pathogenesis and immunity. Indeed, the toxin and its naturally occurring or artificially prepared toxoid have shown promise as protective immunogens. Immunized rabbits were shown to resist intra-intestinal challenge with live vibrios (3) as well as challenge of ileal loops with toxin (11), whereas dogs immunized with toxin plus adjuvant were protected against oral challenge for 10 months (15 Oral challenge. Litter size was maintained at 8 to 10 babies per mother by reducing litters in excess of 10 and adding to those below eight. This was done the day of birth. Babies to be challenged were f'asted overnight when they were 7 days of' age and were grouped by random assignment from litters to be used in a given test. After challenge, the mice were returned to appropriately vaccinated mothers without concern for parentage. Cultures were grown at :37 C on heart infusion agar (HIA) for , and purified cholera toxin ("choleragen"). Commercial vaccine was the least effective immunogen (on a dry-weight basis) against the Ogawa challenge (Fig. 3) . It protected 70% of the mice at the highest test dose of 2 x 108 cells (37.5 ,ug) but offered no protection at the smaller doses of 2 x 107 (3.75 jg) and 2 x 106 cells (0.375 ,ug). Choleragen was somewhat more protective than commercial vaccine, but far less protective than the ribosomal vaccine. HS222 at 0.1 Ag was about as effective as choleragen at 10.0 ,ug. Each protected about 50% of the mice. Significantly, the degree of protection afforded the suckling mice by each vaccine was related to the dose of immunogen given the mother.
The degree of protection conferred by each vaccine against an Inaba (Fig. 4) and an El Tor Ogawa (Fig. 5) challenge was determined. The ribosomal vaccine again proved to be the most effective immunogen. It yielded a protection profile at the three test doses similar to that obtained against Ogawa challenge. The commercial vaccine at the median dose level protected about 70% of the mice challenged with either the Inaba or El Tor strains (see Fig. 4 and 5). The same amount of vaccine gave no protection against Ogawa challenge, as can be seen in Fig. 3 . There was, however, no significant increase in protection when the largest dose of transplacental transfer (1, 16, 18, 20) . Protection against intraperitoneal challenge has been found by Pitkin and Actor (16) to persist for as long as 15 weeks, a duration longer than might be anticipated.
The relative merit of the different vaccines used in these studies depended, in part, on the antigenic dose administered the mothers. Thus the survivorship of the challenged sucklings varied over a dose range of several orders of magnitude. Although all vaccines conferred some degree of protection, the Ogawa-derived HS222 conferred immunity at the smallest dose level and was the most effective against homologous and heterologous challenge. These findings agree with the findings of Pitkin and Actor (16), who used the intraperitoneal route of infection. The material responsible for antigenicity has not been identified, but it may be dependent upon a cell wall or surface component similar to the one described by Verwey (25) . Tests with his preparation are planned and the efficacy of different doses are assessed. It is also important to be in a position to look in detail at the type of immunoglobulins present in the milk and, hopefully, its localization within the intestine. In this way, it should be possible to arrive at some explanation as to why one vaccine is more effective than others.
, ' f~. 
'10
